Allan Cromarty

Allan Cromarty

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2015 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
ATAlet van Tonder
Alet van Tonder
AJAnnie Joubert
Annie Joubert
ACAllan Cromarty
Allan Cromarty
The tetrazolium-based MTT assay has long been regarded as the gold standard of cytotoxicity assays as it is highly sensitive and has been miniaturised for use as a high-throughput screening assay. However, various reports refer to interference by different test compounds, including the glycolysis inhibitor 3-bromopyruvate, with the conversion of the dye to coloured formazan crystals. This study assessed the linear range and reproducibility of three commonly used cell enumeration assays; the neutral red uptake (NRU), resazurin reduction (RES) and sulforhodamine B (SRB) assays, in comparison to the MTT assay. Interference between the MTT assay and three glycolysis inhibitors, 2-deoxyglucose, 3-bromopyruvate and lonidamine, was investigated. Data indicate that the NRU, RES and SRB assays showed the smallest variability across the linear range, while the largest variation was observed for the MTT assay. This implies that these assays would more accurately detect small changes in cell number than the MTT assay. The SRB assay provided the most reproducible results as indicated by the coefficient of determination after a limited number of experiments. The SRB assay also produced the lowest variance in the derived 50% inhibitory concentration (IC50), while IC50 concentrations of 3-bromopyruvate could not be detected using either the MTT or RES assays after 24 hours incubation. Interference in the MTT assay was observed for all three tested glycolysis inhibitors in a cell-free environment. No interferences were observed for the NRU, SRB or RES assays. This study demonstrated that the MTT assay was not the best assay in a number of parameters that must be considered when a cell enumeration assay is selected: the MTT assay was less accurate in detecting changes in cell number as indicated by the variation observed in the linear range, had the highest variation when the IC50 concentrations of the glycolysis inhibitors were determined, and interference between the MTT assay and all the glycolysis inhibitors tested were observed. The SRB assay performed best overall considering all of the parameters, suggesting that it is the most suitable assay for use in preclinical screening of novel therapeutic compounds with oxido-reductive potential.

9 December 2009 in Biology Letters
Verified
Journal Article
Closed access
VNVinny Naidoo
Vinny Naidoo
KWKerri Wolter
Kerri Wolter
ACAllan Cromarty
Allan Cromarty
MDMaria Diekmann
Maria Diekmann
NDNeil Duncan
Neil Duncan
RCRichard Cuthbert
Richard Cuthbert
Three Gyps vulture species are on the brink of extinction in South Asia owing to the veterinary non-steroidal anti-inflammatory drug (NSAID) diclofenac. Carcasses of domesticated ungulates are the main food source for Asia's vultures and birds die from kidney failure after consuming diclofenac-contaminated tissues. Here, we report on the safety testing of the NSAID ketoprofen, which was not reported to cause mortality in clinical treatment of scavenging birds and is rapidly eliminated from livestock tissues. Safety testing was undertaken using captive non-releasable Cape griffon vultures ( Gyps coprotheres ) and wild-caught African white-backed vultures ( G. africanus ), both previously identified as susceptible to diclofenac and suitable surrogates. Ketoprofen doses ranged from 0.5 to 5 mg kg −1 vulture body weight, based upon recommended veterinary guidelines and maximum levels of exposure for wild vultures (estimated as 1.54 mg kg −1 ). Doses were administered by oral gavage or through feeding tissues from cattle dosed with ketoprofen at 6 mg kg −1 cattle body weight, before slaughter. Mortalities occurred at dose levels of 1.5 and 5 mg kg −1 vulture body weight (within the range recommended for clinical treatment) with the same clinical signs as observed for diclofenac. Surveys of livestock carcasses in India indicate that toxic levels of residual ketoprofen are already present in vulture food supplies. Consequently, we strongly recommend that ketoprofen is not used for veterinary treatment of livestock in Asia and in other regions of the world where vultures access livestock carcasses. The only alternative to diclofenac that should be promoted as safe for vultures is the NSAID meloxicam.

3 January 2008 in Journal of Veterinary Pharmacology and Therapeutics
Verified
Journal Article
Closed access
PDF file
VNV. Naidoo
V. Naidoo
KWK. Wolter
K. Wolter
ACAllan Cromarty
Allan Cromarty
PBP. Bartels
P. Bartels
LBL. Bekker
L. Bekker
GSG. E. Swan
G. E. Swan

1 November 2004 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
AFAntonio C. Fernandes
Antonio C. Fernandes
ACAllan Cromarty
Allan Cromarty
CACarl Albrecht
Carl Albrecht
CRChristine Jansen van Rensburg
Christine Jansen van Rensburg

1 August 2018 in Toxicology in Vitro
Verified
Journal Article
Closed access
THTracey Hurrell
Tracey Hurrell
AEAndrea Antonio Ellero
Andrea Antonio Ellero
ZMZelie Flavienne Masso
Zelie Flavienne Masso
ACAllan Cromarty
Allan Cromarty

29 October 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TFTamsyn Fourie
Tamsyn Fourie
ACAllan Cromarty
Allan Cromarty
NDNeil Duncan
Neil Duncan
KWKerri Wolter
Kerri Wolter
VNVinny Naidoo
Vinny Naidoo
The following study evaluates the overt toxic potential of carprofen (CRP), flunixin (FXN) and phenylbutazone (PBZ) in Old world vultures in relation to historic toxicity data for diclofenac and ketoprofen, with the Cape vulture (Gyps coprotheres) being the indicator species. The toxic potential of a single oral dose of CRP (11.5 mg/kg), FXN (1 mg/kg),PBZ (1.7 mg/kg) or water was evaluated by means of a four-way parallel study (n = 2), as means of ascertaining if these drugs were as toxic as diclofenac in the vulture. No unscheduled deaths or pathological lesions were noted following exposure. Clinical signs of lethargy and depression were, however, noted in one CRP, two FXN and one PBZ treated birds. Mild reversible inhibition of UA excretion was evident in all three groups, although UA remained within the population reference interval in contrast to the effects previously described for diclofenac and ketoprofen. All treatment groups had a drug concentration responsive increase in alanine transferase activity. CRP, FXN and PBZ were characterised by a maximum plasma concentration (Cmax) of 1051.8 ± 620.7 ng/ml, 335.9 ± 36.3 ng/ml and 11150 ± 2474.9 ng/ml at 4 ± 4.3, 0.45 ± 0.02 and 5.3 ± 5.2 hours (Tmax) respectively and a half-life of elimination of 13.3 ±5, 1.8±1 and 18.7 ±11.4 hours respectively. While we could not demonstrate a lethal effect of the tested substances, the presence of toxic clinical signs, clinical pathological changes and/or long half-lives of elimination suggests that all three drugs have a potential for toxicity in a larger population or on repeat administration. In conclusion while the studied substances were not as overtly toxic as diclofenac, they are of safety concern.